Cleland, J. G.F. , Pellicori, P. and González, A. (2021) A novel treatment for heart failure targets myocardial fibrosis. Nature Medicine, 27(8), pp. 1343-1344. (doi: 10.1038/s41591-021-01457-9) (PMID:34385705)
Full text not currently available from Enlighten.
Abstract
A new trial suggests that pirfenidone, an approved treatment for idiopathic pulmonary fibrosis, may also reduce myocardial fibrosis in patients with heart failure who have a preserved left ventricular ejection fraction.
Item Type: | Articles |
---|---|
Status: | Published |
Refereed: | Yes |
Glasgow Author(s) Enlighten ID: | Cleland, Professor John and Pellicori, Dr Pierpaolo |
Authors: | Cleland, J. G.F., Pellicori, P., and González, A. |
College/School: | College of Medical Veterinary and Life Sciences > School of Health & Wellbeing > Robertson Centre |
Journal Name: | Nature Medicine |
Publisher: | Nature Research |
ISSN: | 1078-8956 |
ISSN (Online): | 1546-170X |
Published Online: | 12 August 2021 |
University Staff: Request a correction | Enlighten Editors: Update this record